- A symptom that may seem benign could indicate that a person who has already beaten COVID-19 is developing a frightening and potentially deadly complication of the coronavirus.
- Adults are also at risk of developing the same multisystem inflammatory syndrome that has been seen in children who survive COVID-19.
- People who develop a rash a few weeks after clearing their COVID-19 infection may need immediate medical attention for a condition called MIS-A.
The coronavirus statistics include a misleading figure, which will lead many people to think that COVID-19 is not as dangerous as it is rumored. Out of nearly 40 million recorded cases, about 1
Multisystem inflammatory syndrome in children (MIS-C) has also been shown to impact adults and the syndrome is called MIS-A. Both can be frightening and both can lead to life-threatening complications that require hospitalization and even intensive care. These conditions can appear without warning after a coronavirus infection is cleared, but there are sometimes signs that a patient will experience MIS-C or MIS-A.
One of the first symptoms that COVID-19 survivors may see is a rash, NBC News relationships. COVID-19 sometimes features unusual dermatological symptoms, including rashes and a phenomenon called covid finger. But this new rash will appear after COVID-19 is gone.
“Before even seeing the patient,” said Dr. Alisa Femia NBC News, “I said, ‘This hasn’t been reported yet. This must be MIS-A.'” The director of the hospital dermatology department at NYU Langone Health in New York City was looking at a patient file that included several photos. A 45-year-old man had provided treatment to his wife in the previous weeks while she was suffering from COVID-19. The man had “dark red circular spots on the palms of his hands and soles of his feet,” according to NBC. She also had pink eyes and “extremely chapped” lips.
“The skin is right there in front of your eyes,” Femia said. “You can’t miss it.”
Dermatologists may be more likely to see this symptom in patients, but not everyone will link it to MIS-C or MIS-A. However, these rashes appear to be an early indicator of this frightening post-COVID syndrome that some people experience. The condition may be underdiagnosed in adults because many doctors don’t even know they are looking for it.
Aside from rashes, these patients may experience symptoms that can appear in COVID-19 and other conditions, including fever, chest pain, heart problems, and gastrointestinal problems. Basically, MIS-A patients would not exhibit a key symptom of severe COVID-19, which is shortness of breath. Their COVID-19 PCR tests would return negative results, while the antibody tests may be positive, suggesting a recent recovery from the infection.
Doctors are still unable to fully explain what causes inflammation within the body after the new coronavirus is eliminated, but MIS-C and MIS-A can both be deadly. Currently, there are no guaranteed cures for these inflammatory syndromes in COVID-19 survivors.
NBC reports that children are usually treated with intravenous immunoglobulin, an antibody treatment that has nothing to do with the COVID-19 antibodies that plasma transfers would provide. Adults are often given steroids and interleukin-6 inhibitors as they have already developed COVID-19 antibodies. Some doctors he spoke to NBC theorize that it is coronavirus antibodies that could cause MIS-A. But this is speculation for the moment as there is no definitive evidence to support it.